Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Shl Telemedicine ( (CH:SHLTN) ).
SHL Telemedicine reported stable revenues of USD 27.9 million for the first half of 2025, with improvements in Israeli operations offset by declines in Germany. The company plans a capital raise of up to USD 30 million to enhance financial flexibility and support business development, including upgrading German operations and penetrating the U.S. market. The acquisition of the remaining stake in Mediton Group is also underway, with legal proceedings scheduled regarding minority shareholders’ disagreements.
More about Shl Telemedicine
SHL Telemedicine is a company engaged in the development and marketing of personal telemedicine systems and medical call center services, primarily focusing on cardiovascular and related diseases. They provide services and devices to subscribers using telephonic and Internet communication technology and are listed on the SIX Swiss Exchange.
Average Trading Volume: 2,962
Current Market Cap: CHF21.8M
See more data about SHLTN stock on TipRanks’ Stock Analysis page.